Liver-Function Studies in Heart-
(mean and range) for serum bilirubin, bile acids,GGT, and ABT in patients with normal liver function0 (group I, n 7), mildlyalteredliver function (group II, n = 5) , and severely altered liver function (group III, n = 5) (n = 5, severely altered liver function).
By this evaluation, therefore, 10 of the 17 patients displayed preoperative liver dysfunction, presumably owing to heart-induced changes.
Immunosuppression. 
Post-transplantation

follow-up of liver function.
Concentrations of ALT, GOT, AP, BA, bilirubin,
and CsA in serum were followed for all the patients: before operation, daily during the first 14 postoperative days, and on day 30 (at 0800, 12 h after the last oral dose of CsA). 
Results
Pre-transplantation
The preoperative values compared
with the values on day 30 were: group I from 4.8% (3-6%) to 6.7% (3.2-9.6%); group H from 4% (3-5%) to 3.6% (3-7%); group ill On the other hand, increased concentrations of bile acids in serum were observed from day 4 to day 14, and on day 30 only in group ifi ( Figure  3) ; GOT values were also significantly increased when compared with pre-HTx values, but only on day 30 for all the patients of this group (data not shown).
These increases were not observed in any of the other groups.
CsA doses decreased significantly (P <0.001) from group I to group Ill (mean and SD), respectively-6.5 ± 0.8,4.5 ± 0.9, and 2.9 ± 0.9 mg per kilogram body weight per day-to achieve the same "trough" GOT was also reported to be irregularly an inexplicably increased for months after heart transpianta tion in 20 patients receiving CsA (6). Because no clear-cu effect on GOT was demonstrated in our kinetic studies, direct relationship between CSA and postoperative increas in GOT in group ifi patients cannot be postulated.
In conclusion, our heart-transplant recipients treate with CsA did not show signs of hepatotoxicity. However, direct effect of CsA on bile acids excretion was clearl
demonstrated.
Further experiments will be needed to clarif the physiological mechanism responsible for the effect o CSA on bile clearance, albeit already described on anima models (13, 14-16).
